Maha Guindi, MD

Director, Gastrointestinal and Liver Pathology
Director, Gastrointestinal/Liver Pathology Fellowship
Medical Director, Digital and Telepathology

Clinical Specialties:
Gastrointestinal Pathology
Liver Pathology

Email: Maha.Guindi@cshs.org
Phone: 310-423-6623

Education and Training

  • University of Cairo, MBBCH
  • Residency in Anatomic Pathology, Ottawa Hospital - University of Ottawa, Canada
  • Fellowship in Liver Pathology, Toronto Hospital, University of Toronto, Canada
  • Fellowship in Gastrointestinal Pathology, McMaster University, Ontario, Canada

Medical Board Certification

  • Board Certified, Anatomic Pathology American Board of Pathology
  • Board Certified, Anatomical Pathology, Royal College of Physicians and Surgeons (Canada)

Clinical and Research Interests

  • Hepatobiliary neoplasia
  • Liver fibrosis and autoimmune liver disease
  • Inflammatory bowel disease
  • Esophageal carcinoma, pathology related to neoadjuvant chemotherapy and radiotherapy

Awards and Activities

  • Former Director, Pathology Residency and GI-Liver Pathology Fellowship, University Health Network teaching hospital, Toronto, Canada.
  • Ambassador of the United States and Canadian Academy of Pathology
  • Recipient of the Wighman-Berris Award for Excellence in Undergraduate Teaching, University of Toronto, and the University of Ottawa Award for Outstanding Contribution in Medical Education
  • Member, Abstract Review Board , United States and Canadian Academy of Pathology

Selected Publications

  • Ko MA, Zehong G, Virtanen C, Guindi M, Waddell TK, Keshavjee S, Darling GE.  MicroRNA Expression Profiling of Esophageal Cancer Before and After Induction Chemoradiotherapy.  Ann Thorac Surg. 2012 Aug 28. [Epub ahead of print]\
  • Pattullo V, Thein HH, Heathcote EJ, Guindi M.  Combining semiquantitative measures of fibrosis and qualitative features of parenchymal remodelling to identify fibrosis regression in hepatitis C: a multiple biopsy study.  Histopathology. 2012;61:473-487.
  • Dinani AM, Fischer SE, Mosko J, Guindi M, Hirschfield GM.  Patients with autoimmune hepatitis who have antimitochondrial antibodies need long-term follow-up to detect late development of primary biliary cirrhosis.  Clin Gastroenterol Hepatol. 2012;10:682-4.
  • McGilvray I, Feld JJ, Chen L, Pattullo V, Guindi M, Fischer S, Borozan I, Xie G, Selzner N, Heathcote EJ, Siminovitch K. Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotype.  Gastroenterology. 2012;142:1122-1131.
  • Khalili K, Kim TK, Jang HJ, Yazdi LK, Guindi M, Sherman M.  Indeterminate 1-2-cm nodules found on hepatocellular carcinoma surveillance: biopsy for all, some, or none?  Hepatology 2011;54:2048-54.

Click here for a list of peer-reviewed publications by Maha Guindi, MD.

print button
WP3